390
Participants
Start Date
March 31, 2005
Study Completion Date
November 30, 2006
Pregabalin
Venlafaxine XR
Pfizer Investigational Site, De Pinte
Pfizer Investigational Site, Ghent
Pfizer Investigational Site, Waregem
Pfizer Investigational Site, Kelowna
Pfizer Investigational Site, Hamilton
Pfizer Investigational Site, Ottawa
Pfizer Investigational Site, Gatineau
Pfizer Investigational Site, Saint-Jean-sur-Richelieu
Pfizer Investigational Site, Angoulême
Pfizer Investigational Site, Arcachon
Pfizer Investigational Site, Bully-les-Mines
Pfizer Investigational Site, Cherbourg
Pfizer Investigational Site, Élancourt
Pfizer Investigational Site, Orvault
Pfizer Investigational Site, Rennes
Pfizer Investigational Site, Saint-André-de-Cubzac
Pfizer Investigational Site, Savigny-sur-Orge
Pfizer Investigational Site, Strasbourg
Pfizer Investigational Site, Versailles
Pfizer Investigational Site, Bray
Pfizer Investigational Site, Vicenza
Pfizer Investigational Site, Città di Castello
Pfizer Investigational Site, Catania
Pfizer Investigational Site, Sassari
Pfizer Investigational Site, Wildervank
Pfizer Investigational Site, Hoogvliet
Pfizer Investigational Site, Huizen
Pfizer Investigational Site, Losser
Pfizer Investigational Site, Musselkanaal
Pfizer Investigational Site, Oude Pekela
Pfizer Investigational Site, Vic
Pfizer Investigational Site, Alcalá de Henares
Pfizer Investigational Site, Langreo
Pfizer Investigational Site, Gandia
Pfizer Investigational Site, Barcelona
Pfizer Investigational Site, Madrid
Pfizer Investigational Site, Salamanca
Pfizer Investigational Site, Zamora
Pfizer Investigational Site, Gothenburg
Pfizer Investigational Site, Linköping
Pfizer Investigational Site, Lund
Pfizer Investigational Site, Malmo
Pfizer Investigational Site, Stockholm
Pfizer Investigational Site, Sundsvall
Pfizer Investigational Site, Trollhättan
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
INDUSTRY